1.88

1.88 (-0.79%)

As of Feb 23, 2024

BRIGHT MINDS BIOSCIENCES INC. [DRUG]

Source: 

Company Overview

The Company is a biotechnology company dedicated to developing the next-generation therapeutics to improve the lives of patients with severe and life-altering diseases. The Company is focused on new chemical entities (NCEs) for a variety of central nervous system disorders, including but not limited to pediatric epilepsies, as well as other neuro-psychiatric disorders, including but not limited to depression. The Company's R&D efforts focus on medical indications based on its expertise in 5-HT (serotonin) mediated diseases.

CountryUS
Headquartersnew yorknew york
Phone Number(647) 407-2515
Industry
CEOIan Mcdonald
Websitebrightmindsbio.com

Recent Stories